ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

It remains unclear how programmed death-ligand 1 (PD-L1) expression interacts with anaplastic lymphoma kinase (ALK) mutation, its variants, and the outcome of treatment. One hundred and twenty four out of 1255 patients (9.9%) were deemed ALK-positive by the Ventana IHC assay. PD-L1 status and ALK va...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Gee-Chen, Yang, Tsung-Ying, Chen, Kun-Chieh, Hsu, Kuo-Hsuan, Huang, Yen-Hsiang, Su, Kang-Yi, Yu, Sung-Liang, Tseng, Jeng-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713243/
https://www.ncbi.nlm.nih.gov/pubmed/33273548
http://dx.doi.org/10.1038/s41598-020-78152-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713243/
https://www.ncbi.nlm.nih.gov/pubmed/33273548
http://dx.doi.org/10.1038/s41598-020-78152-1

Ejemplares similares